期刊文献+

野黄芩苷对人舌鳞癌Tca8113细胞Fas和FasL表达的影响 被引量:1

EFFECTS OF SCUTELLARIN ON EXPRESSION OF FAS AND FASL IN HUMAN TONGUE SQUAMOUS CARCINOMA TCA8113 CELLS
下载PDF
导出
摘要 目的:观察野黄芩苷对人舌鳞癌Tca8113细胞Fas和Fas L表达的影响。方法:体外培养人舌鳞癌Tca8113细胞分为对照组、不同浓度野黄芩苷药物组,野黄芩苷组分别用80μg/ml、120μg/ml、160μg/ml的野黄芩苷作用人舌鳞癌Tca8113细胞48h。采用免疫细胞化学法观察野黄芩苷对人舌鳞癌Tca8113细胞Fas和FasL表达的影响。结果:用药组Tca8113细胞Fas和FasL的表达水平明显高于对照组(P<0.05);并且随着野黄芩苷药物浓度的增加,Fas和FasL的表达水平逐渐升高(P<0.05)。结论:野黄芩苷可能通过促进人舌鳞癌Tca8113细胞Fas蛋白和FasL蛋白的表达促进肿瘤细胞凋亡。 Objective:To observe the effects of scutellarin on expression of Fas and FasL in human tongue squamous carcinoma Tca8113 cells.Methods:Human tongue squamous carcinoma Tca8113 cells were cultured in vitro and divided into control group and 3 scutellarin groups with different concentrations(80μg/ml,120μg/ml,160μg/ml).Immunocytochemical stain was used to detect the expression of Fas and FasL in human tongue squamous carcinoma Tca8113 cells.Results:The Fas and FasL expression level in Tca8113 cells of scutellarin groups was obviously higher than that of control group(P〈0.05);Moreover,with increasing of scutellarin concentrations,the Fas and FasL expression increased gradually(P〈0.05).Conclusions:Scutellarin may promote tumour cells apoptosis by upregulating the expression of Fas and FasL in human tongue squamous carcinoma Tca8113 cells.
出处 《承德医学院学报》 2016年第1期7-9,共3页 Journal of Chengde Medical University
关键词 野黄芩苷 人舌鳞癌Tca8113细胞 FAS FasL Scutellarin Human tongue squamous carcinoma Tca8113 cells Fas FasL
  • 相关文献

参考文献9

  • 1Parkin DM,Bmy F,Ferlay J,et al.Global cancer statistics,2002[J]. CA Cancer J Clin,2005, 55(2):74-108.
  • 2Sano D,Myers JN.Metastasis of squamous cell carcinoma of oral tongue[J].Cancer Metastasis Rev,2007,26(3-4):645-662.
  • 3Chung CP, Park JB,Bae KH.Pharmacological effects ofmethanolic exlract from the root of scutellaria baicnAensis and its fiavonoids on human gingival fibroblast[J]. Planta Med, 1995, 61 (2): 150-153.
  • 4杨鹤松.黄芩茎叶总黄酮对LA795小鼠肺腺癌的抑制作用[J].承德医学院学报,2008,25(4):439-439. 被引量:8
  • 5Chan JY, Tan BK,Lee SC.Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation[J]. Anticancer Rest009,29(8):3043-3047.
  • 6Nagata S,Golstein P.The Fas death factor[J].Science,1995,267 (5203):1449-1456.
  • 7Wajant H.The Fas signaling pathway: more than a paradigm[J]. Scieaace,2002,296(5573): 1635-1636.
  • 8王建广,黄洪章,潘朝斌,侯劲松,李劲松,程斌.口腔鳞状细胞癌Fas基因表达与细胞凋亡关系的研究[J].华西口腔医学杂志,2004,22(4):334-336. 被引量:6
  • 9Muraki Y, Tateishi A,Seta C,et al.Fas antigen expression and outcome of oral squamous cell carcinoma[J].Int J Oral Maxillofac Surg,2000,29(5):360-365.

二级参考文献10

  • 1[1]Marie JS, Eoin FG. Apoptosis, basic concepts and potential significance in human cancer[J]. Arch Pathol Lab Med, 1998,122(4): 310-319.
  • 2[2]Kerr JFR, Wyllie AH, Currie AR. Apoptosis, a basic biological phenomenon with wide-ranging inplifications in tissue kinetics [ J ]. Br J Cancer, 1972,26(4) :239-257.
  • 3[3]Reyher KM, Strater J, Kittstein W, et al. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis[J]. Cancer Res, 1998,58(3) :526-534.
  • 4[4]Fenton RG, Hixon JA, Wright PW, et al. Inhibition of Fas expression and Fas mediated apoptosis by oncogene Ras[J]. Cancer Res, 1998,58(15): 3391-3400.
  • 5[5]Steller H. Mechanism and genes of cellular sucide [J]. Science,1990, 250 (23):1149-1151.
  • 6[6]Nagata S, Golstein P. The Fas death factor[J]. Science, 1995,267(10): 1449-1456.
  • 7[7]Itoh N, Nagata S. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen[J]. J Biol Chem, 1993,2.68(15): 10932-10937.
  • 8[8]Boldin MP, VarfolomeerEE, PancerZ, etal. A novel protein that interacts with the death domain of Fas contains a sequence motif related to the death donain[J]. J Biol Chem, 1995,270(14):7795-7798.
  • 9[9]Catherine G, YasuoT, ChristophB, etal. Upregulation of Fas ligand and down regulation of Fas expression in human Esophageal cancer[J].Cancer Res, 1998,58(10) :2057-2062.
  • 10[10]Pizer ES, Lax SF, Kuhajda FP, et al. Fatty acid synthase expression in endometrial carcinoma[J]. Cancer, 1998,83(3):528-537.

共引文献12

同被引文献16

引证文献1

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部